HOME › DRUGS › ORITAVANCIN DIPHOSPHATE
ACTIVE SUBSTANCE / INN

ORITAVANCIN DIPHOSPHATE

Brand name(s): KIMYRSA, ORBACTIV
FDA LISTED
PRESCRIPTION
NDA214155
NDA206334
ACTIVE SUBSTANCE
Oritavancin Diphosphate
REGULATORS
FDA
SPONSORS / MAH
MELINTA THERAP
TOTAL APPLICATIONS
2
FDA APPLICATIONS (DRUGS@FDA)
BRAND NAMEAPPLICATIONSPONSORSTATUS
ORBACTIVNDA206334MELINTA THERAPPrescription
KIMYRSANDA214155MELINTA THERAPPrescription

FULL INTELLIGENCE ON ORITAVANCIN DIPHOSPHATE

Patent cliffs, clinical trials, pipeline data, AI-enriched regulatory signals — free on PharmaSignal.

OPEN PLATFORM →